Shiro Fujita

TL;DR: The use of small-for-size grafts (less than 1% of recipient body weight) leads to lower graft survival, probably through enhanced parenchymal cell injury and reduced metabolic and synthetic capacity.

TL;DR: It is suggested that the meticulous management of surgical factors at each stage of the LRLT procedure is crucial for successful outcome and may be regarded as an independent modality to supplement cadaver donation.

TL;DR: Right lobe grafting is a safe and effective procedure, resulting in the expansion of the indication for LDLT to large-size recipients and how to deal with the possible variation in the anatomy of the right lobe graft should be given attention throughout the procedure.

TL;DR: A majority of long-term patients undergoing living donor liver transplantation may be potential candidates to be successfully weaned from immunosuppression, and the mechanism of graft acceptance in these patients has yet to be elucidated.

TL;DR: Univariative analysis revealed that the manner of stent usage, intrapulmonary shunting, and gender of recipients were significant risk factors for leakage and stricture after living related liver transplantation, and avoidance of ABO-incompatible donors or innovative immunosuppression in ABO -incompatible transplantation should be considered in children.